Clik here to view.
Lyndra raises $23m for long-acting drug delivery tech
Lyndra, Inc. said today that it closed a $23m Series A round, led by Polaris Partners, to fund the development of its long-acting therapeutic oral delivery platform. Quark Venture, GF Securities,...
View ArticleClik here to view.
Nanoparticle nasal spray targets drugs to the brain
Drug delivery to the brain could 1 day be as simple as a sniff, according to engineers at Washington University that developed a new nanoparticle-based delivery technique. “This would be a nanoparticle...
View ArticleClik here to view.
Sanofi promotes Sibold to exec VP of Sanofi Genzyme | Personnel Moves – April...
Sanofi (NYSE:SNY) said at the start of April that it promoted Bill Sibold to exec VP of Sanofi Genzyme, effective July 1, 2017. Sibold succeeds Dr. David Meeker, who is slated to leave the company at...
View ArticleClik here to view.
BD warns customers about injury reports from Eclipse needle
Becton Dickinson warned customers and business partners that it has received reports of needlestick injury for its BD Eclipse needle, used in transfusion procedures. Arrow International, which uses...
View ArticleClik here to view.
Livongo, Glytec ink deal for electronic diabetes management solution
Digital Health company Livongo Health said today that it is partnering with Glytec to develop a diabetes management solution that includes insulin titration. The companies plan to expand Glytec’s...
View ArticleClik here to view.
Imprimis, Precision Lens sign marketing and sales agreement
Imprimis Pharmaceuticals (NSDQ:IMMY) said today that it signed a 3-year exclusive sales agreement with Precision Lens. According to the deal, Precision Lens plans to deploy a sales team to expand...
View ArticleClik here to view.
Milestone Scientific lands marketing clearance in Saudi Arabia, Australia
Milestone Scientific (NYSE:MLSS) shares rose today after the company said it won marketing clearance in Saudi Arabia, weeks after winning a regulatory nod in Australia for its epidural and...
View ArticleClik here to view.
Parvus inks exclusive license with Novartis for T1D nanomedicine
Parvus Therapeutics said today that it signed an exclusive worldwide license and collaboration deal with Novartis (NYSE:NVS) for its type 1 diabetes nanodrug, Navacim. The therapeutic candidate is made...
View ArticleClik here to view.
First European patients treated with BTG’s drug-eluting bead
BTG (LON:BTG) said today that the 1st batch of patients in the European Union were treated with its DC Bead Lumi radiopaque drug-eluting bead. Two patients were treated for hepatocellular carcinoma and...
View ArticleTargeted drug delivery system releases chemo drug for 40 days
Researchers at Case Western Reserve University have developed a targeted drug delivery system that is triggered by the acidic environment around a tumor. The system delivers chemotherapy to the tumor...
View ArticleClik here to view.
Teva launches AirDuo RespiClick, generic inhaled asthma therapies
Teva Pharmaceutical (NYSE:TEVA) said today that it launched the AirDuo RespiClick inhalation therapy and its authorized generic in the U.S. for asthma patients who are uncontrolled on an inhaled...
View ArticleClik here to view.
Clearside closes patient enrollment in trial for diabetic macular edema therapy
Clearside Biomedical (NSDQ:CLSD) said today that it finished enrollment for the Phase 1/2 study of CLS-TA in patients with diabetic macular edema. The Hulk trial is designed to evaluate the safety and...
View ArticleClik here to view.
Medicaid expansion tied to increase in prescriptions for diabetes drugs,...
The number of prescriptions filled by adults using Medicaid rose 19% in states that expanded Medicaid compared to states that did not under the Affordable Care Act, according to a new study from the...
View ArticleClik here to view.
Hospira, Baxter subpoenaed in antitrust probe over intravenous saline
Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions. ICU Medical (NSDQ:ICUI),...
View ArticleClik here to view.
Mallinckrodt, Marathon leave industry trade group over drug pricing controversy
Marathon Pharmaceuticals reportedly withdrew from the drug industry’s lobbying group yesterday following controversy over its pricey drug, Emflaza. Pharmaceutical Research and Manufacturers of America...
View ArticleClik here to view.
Trump to meet with biotech execs, researchers to discuss federal funding
In the wake of President Donald Trump’s $6 billion proposed cut to the National Institutes of Health, biotech executives and researchers are slated to meet with the new administration next month. A...
View ArticleClik here to view.
Sanofi levels antitrust suit against Mylan over EpiPen device
Sanofi (NYSE:SNY) reportedly sued Mylan (NSDQ:MYL) today, accusing the company of illegally suppressing competition to the EpiPen device. The lawsuit filed in a New Jersey federal court alleges that...
View ArticleClik here to view.
Portal wins ISO certification for needle-free drug delivery device
Medical device start-up Portal Instruments said today that it won ISO 13485:2012 certification from the National Standards Authority of Ireland. The Cambridge, Mass.-based company is developing a...
View ArticleClik here to view.
Eli Lilly’s diabetes drugs boost Q1 revenue, earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year –...
View ArticleClik here to view.
Fresenius acquires generics drugmaker Akorn, Merck’s biosimilars biz
German healthcare company Fresenius (ETR:FRE) said today that it bought U.S. generic drugmaker Akorn Inc. (NSDQ:AKRX) for $4.75 billion and Merck KGaA’s biosimilars business. Since chief executive...
View Article